Jerrold Grossman's Insider Trades & SAST Disclosures
Jerrold Grossman's most recent trade in Adma Biologics Inc was a trade of 16,279 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jerrold Grossman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 16,279 | 16,279 | - | - | Stock Option (Right to Buy) | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 10,889 | 478,194 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Sale of securities on an exchange or to another person at price $ 17.27 per share. | 29 Aug 2024 | 136,861 | 467,305 (0%) | 0% | 17.3 | 2,363,932 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.66 per share. | 29 Aug 2024 | 118,861 | 586,166 (0%) | 0% | 3.7 | 435,031 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 118,861 | 0 | - | - | Common Stock | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.80 per share. | 29 Aug 2024 | 9,000 | 604,166 (0%) | 0% | 10.8 | 97,200 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.96 per share. | 29 Aug 2024 | 9,000 | 595,166 (0%) | 0% | 6.0 | 53,640 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 9,000 | 0 | - | - | Common Stock | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 9,000 | 0 | - | - | Common Stock | |
| Adma Biologics Inc | B. Jerrold Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 37,541 | 37,541 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Grossman Jerrold B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 24,040 | 467,305 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 3.71 per share. | 30 Aug 2023 | 130,000 | 443,265 (0%) | 0% | 3.7 | 482,144 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 51,630 | 51,630 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 25,815 | 313,265 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 53,172 | 53,172 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 26,586 | 287,450 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 25 Oct 2021 | 100,000 | 260,864 (0%) | 0% | 1 | 100,000 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 10 Sep 2020 | 5,000 | 160,864 (0%) | 0% | 2.2 | 11,100 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 2.56 per share. | 21 Aug 2020 | 5,000 | 155,564 (0%) | 0% | 2.6 | 12,800 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 21 Aug 2020 | 300 | 155,864 (0%) | 0% | 2.6 | 786 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 2.89 per share. | 12 Aug 2020 | 5,000 | 145,564 (0%) | 0% | 2.9 | 14,450 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 12 Aug 2020 | 5,000 | 150,564 (0%) | 0% | 2.9 | 14,475 | Common Stock |
| Adma Biologics Inc | Jerrold B. Grossman | Director | Purchase of securities on an exchange or from another person at price $ 2.87 per share. | 12 Aug 2020 | 200 | 140,564 (0%) | 0% | 2.9 | 574 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges